Lead and scale Lexeo’s marketing organization to shape brand strategy, launch readiness, and commercial planning for first-in-class AAV gene therapies in genetic cardiomyopathies.
Lead commercial and corporate strategy for Lexeo’s cardiac gene-therapy programs, translating market insights into go-to-market plans and pipeline prioritization.